BB Biotech
Latest statistics and disclosures from Bb Biotech's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IONS, INCY, NBIX, VRTX, SAGE, and represent 42.56% of Bb Biotech's stock portfolio.
- Added to shares of these 10 stocks: CRSP (+$29M), Audentes Therapeutics (+$23M), NKTR (+$22M), Myokardia (+$20M), Intercept Pharmaceuticals In (+$14M), SGMO (+$12M), KZR (+$7.1M), AGIO (+$6.7M), ALNY (+$5.6M), ESPR (+$5.2M).
- Started 2 new stock positions in Homology Medicines, CRSP.
- Reduced shares in these 7 stocks: IONS (-$83M), , INCY (-$16M), VRTX (-$13M), GILD (-$12M), Celgene Corporation (-$9.8M), Akcea Therapeutics Inc equities.
- Sold out of its position in REGN.
- Bb Biotech was a net seller of stock by $-513k.
- Bb Biotech has $4.0B in assets under management (AUM), dropping by 27.44%.
- Central Index Key (CIK): 0000924223
Tip: Access up to 7 years of quarterly data
Positions held by BB Biotech consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Bb Biotech
Bb Biotech holds 35 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals (IONS) | 15.8 | $627M | -11% | 7.7M | 81.17 |
|
| Incyte Corporation (INCY) | 7.8 | $311M | -4% | 3.6M | 86.01 |
|
| Neurocrine Biosciences (NBIX) | 7.5 | $297M | 3.4M | 88.10 |
|
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 6.0 | $239M | -5% | 1.3M | 183.95 |
|
| Sage Therapeutics (SAGE) | 5.5 | $219M | 1.4M | 159.05 |
|
|
| Celgene Corporation | 5.2 | $208M | -4% | 2.2M | 94.34 |
|
| Agios Pharmaceuticals (AGIO) | 5.0 | $201M | +3% | 3.0M | 67.44 |
|
| Alexion Pharmaceuticals | 4.5 | $178M | 1.3M | 135.18 |
|
|
| Alnylam Pharmaceuticals (ALNY) | 3.8 | $152M | +3% | 1.6M | 93.45 |
|
| Esperion Therapeutics (ESPR) | 3.6 | $141M | +3% | 3.5M | 40.15 |
|
| Radius Health | 3.4 | $135M | 6.8M | 19.94 |
|
|
| Halozyme Therapeutics (HALO) | 3.4 | $134M | 8.3M | 16.10 |
|
|
| Argenx Se (ARGX) | 2.8 | $113M | +2% | 905k | 124.84 |
|
| Moderna (MRNA) | 2.5 | $97M | 4.8M | 20.35 |
|
|
| Myovant Sciences | 2.2 | $86M | 3.6M | 23.87 |
|
|
| Intercept Pharmaceuticals In | 2.0 | $78M | +21% | 697k | 111.86 |
|
| Gilead Sciences (GILD) | 1.9 | $74M | -14% | 1.1M | 65.01 |
|
| Nektar Therapeutics (NKTR) | 1.7 | $68M | +46% | 2.0M | 33.60 |
|
| Exelixis (EXEL) | 1.7 | $68M | 2.8M | 23.80 |
|
|
| Akcea Therapeutics Inc equities | 1.7 | $67M | 2.4M | 28.33 |
|
|
| Myokardia | 1.6 | $66M | +44% | 1.3M | 51.99 |
|
| Macrogenics (MGNX) | 1.5 | $61M | +3% | 3.4M | 17.98 |
|
| Wave Life Sciences (WVE) | 1.4 | $57M | 1.5M | 38.85 |
|
|
| Voyager Therapeutics (VYGR) | 1.4 | $55M | 2.9M | 19.14 |
|
|
| Audentes Therapeutics | 1.3 | $53M | +78% | 1.4M | 39.02 |
|
| Alder Biopharmaceuticals | 0.9 | $38M | 2.8M | 13.65 |
|
|
| Crispr Therapeutics (CRSP) | 0.7 | $29M | NEW | 811k | 35.72 |
|
| Scholar Rock Hldg Corp (SRRK) | 0.7 | $28M | +15% | 1.5M | 18.79 |
|
| Intra Cellular Therapies (ITCI) | 0.7 | $27M | 2.2M | 12.18 |
|
|
| Sangamo Biosciences (SGMO) | 0.6 | $25M | +96% | 2.7M | 9.54 |
|
| Kezar Life Sciences (KZR) | 0.5 | $22M | +49% | 1.2M | 17.74 |
|
| G1 Therapeutics | 0.3 | $11M | 672k | 16.60 |
|
|
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.1 | $6.1M | 2.3M | 2.65 |
|
|
| Novavax | 0.1 | $4.6M | 8.3M | 0.55 |
|
|
| Homology Medicines | 0.1 | $2.5M | NEW | 91k | 27.73 |
|
Past Filings by Bb Biotech
SEC 13F filings are viewable for Bb Biotech going back to 2010
- Bb Biotech 2019 Q1 filed May 13, 2019
- Bb Biotech 2018 Q4 filed Feb. 12, 2019
- Bb Biotech 2018 Q3 filed Nov. 9, 2018
- Bb Biotech 2018 Q2 filed Aug. 9, 2018
- Bb Biotech 2018 Q1 filed May 8, 2018
- Bb Biotech 2017 Q4 filed Feb. 14, 2018
- Bb Biotech 2017 Q3 filed Nov. 13, 2017
- Bb Biotech 2017 Q2 filed Aug. 11, 2017
- Bb Biotech 2017 Q1 filed May 10, 2017
- Bb Biotech 2016 Q4 filed Feb. 14, 2017
- Bb Biotech 2016 Q3 filed Nov. 10, 2016
- Bb Biotech 2016 Q2 filed Aug. 12, 2016
- Bb Biotech 2016 Q1 filed May 12, 2016
- Bb Biotech 2015 Q4 filed Feb. 9, 2016
- Bb Biotech 2015 Q3 filed Nov. 12, 2015
- Bb Biotech 2015 Q2 filed Aug. 12, 2015